NYSE American - Nasdaq Real Time Price USD

Cryo-Cell International, Inc. (CCEL)

Compare
5.84 -0.21 (-3.43%)
At close: October 15 at 2:22 PM EDT
6.25 +0.41 (+6.98%)
Pre-Market: 8:01 AM EDT
Loading Chart for CCEL
DELL
  • Previous Close 6.05
  • Open 6.00
  • Bid --
  • Ask --
  • Day's Range 5.77 - 5.85
  • 52 Week Range 3.67 - 9.50
  • Volume 2,591
  • Avg. Volume 3,725
  • Market Cap (intraday) 47.102M
  • Beta (5Y Monthly) 0.53
  • PE Ratio (TTM) --
  • EPS (TTM) -1.11
  • Earnings Date Oct 15, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 1, 2022
  • 1y Target Est 11.00

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

www.cryo-cell.com

82

Full Time Employees

November 30

Fiscal Year Ends

Recent News: CCEL

View More

Performance Overview: CCEL

Trailing total returns as of 10/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CCEL
1.61%
S&P 500
21.92%

1-Year Return

CCEL
18.51%
S&P 500
34.37%

3-Year Return

CCEL
48.77%
S&P 500
31.03%

5-Year Return

CCEL
18.24%
S&P 500
96.05%

Compare To: CCEL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CCEL

View More

Valuation Measures

Annual
As of 10/15/2024
  • Market Cap

    48.78M

  • Enterprise Value

    60.96M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.49

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.87

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -29.38%

  • Return on Assets (ttm)

    -0.25%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    31.64M

  • Net Income Avi to Common (ttm)

    -9.3M

  • Diluted EPS (ttm)

    -1.11

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.53M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -9.52M

Research Analysis: CCEL

View More

Company Insights: CCEL

Research Reports: CCEL

View More

People Also Watch